TATE & LYLE PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 709.00 GBX | -0.49% |
|
-3.80% | +7.59% |
| Dec. 03 | RBC raises Ashtead; Deutsche Bank cuts Currys | AN |
| Nov. 18 | Tate & Lyle issues shares to complete purchase of CP Kelco | AN |
Summary: Tate & Lyle plc
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Highlights: Tate & Lyle plc
- Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 46% by 2027.
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses: Tate & Lyle plc
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Ratings Chart: Tate & Lyle plc
Source: Surperformance
ESG chart: Tate & Lyle plc
Source: Refinitiv
| Composite Fundamentals | Composite Valuation | Composite Momentum | Capi. ($) | ||
|---|---|---|---|---|---|
| 4.01B | |||||
| 35.49B | |||||
| 22.74B | |||||
| 10.61B | |||||
| 4.95B | |||||
| 4.21B | |||||
| 4.1B | |||||
| 3.2B | |||||
| 2.44B | |||||
| 2.03B | |||||
| Average | 9.38B | ||||
| Weighted average by Cap. |
Investor Rating
Trading Rating
ESG Refinitiv
B+
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- TATE Stock
- Ratings Tate & Lyle plc